Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-026085
Filing Date
2021-04-08
Accepted
2021-04-08 16:56:11
Documents
2
Period of Report
2021-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5274
2 POA DOCUMENT poa.txt EX-24.3_978596 3050
  Complete submission text file 0001209191-21-026085.txt   9699
Mailing Address C/O LUMENA PHARMACEUTICALS, INC. 12531 HIGH BLUFF DRIVE, SUITE 110 SAN DIEGO CA 92130
Business Address
Dorenbaum Alejandro (Reporting) CIK: 0001606083 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 21815399

Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations